Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Applicability of Pseudo-continuous Arterial Spin Labeling as a Substitute for FDG-position Emission Tomography in MCI and SCD Patients

NCT05756270 is registered in ClinicalTrials.gov with University of Milano Bicocca as lead sponsor.

NCT NCT05756270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05756270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Applicability of Pseudo-continuous Arterial Spin Labeling as a Substitute for FDG-position Emission Tomography in MCI and SCD Patients
Lead sponsor
University of Milano Bicocca
Phase
Observational
Overall status
Completed
Start date
June 3, 2022
Completion date
March 1, 2026
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment, subjective cognitive decline